| 1995 |
RanBP1 (23 kDa) binds tightly to Ran-GTP but not Ran-GDP, co-activates RanGAP1-induced GTP hydrolysis by ~10-fold, inhibits RCC1-stimulated nucleotide exchange on Ran, and forms a stable complex with nucleotide-free RCC1-Ran. It defines a new class of GTPase regulators distinct from GDIs. |
In vitro GTPase and nucleotide exchange assays with purified recombinant proteins; biochemical fractionation |
The EMBO journal |
High |
7882974
|
| 1995 |
The acidic C-terminal -DEDDDL sequence of Ran is required for high-affinity interaction with RanBP1 (HTF9A); deletion of this domain reduces RanBP1 affinity to ~10 µM and converts RanBP1 from a RanGAP co-activator to a RanGAP inhibitor. |
In vitro binding assays, GTPase activity assays with C-terminal deletion mutants of Ran |
The Journal of biological chemistry |
High |
7782302
|
| 1995 |
RanBP1 binds RCC1 only in the presence of Ran (forming a trimeric complex) and inhibits RCC1-stimulated guanine nucleotide release from Ran in vitro. Overexpression of RanBP1 is detrimental in RCC1-deficient cells, establishing it as a negative regulator of RCC1. |
Two-hybrid interaction screen, in vitro GST pulldown, in vitro nucleotide exchange assay, yeast genetics (rcc1 mutant complementation/suppression) |
Molecular & general genetics : MGG |
High |
7616957
|
| 1996 |
RanBP1 forms a trimeric complex with p97 (importin-β) and Ran, stabilizes the interaction of Ran-GDP with p97, promotes nuclear import by stabilizing receptor docking at the pore, and stimulates translocation in a permeabilized cell import assay. |
Immunoadsorption from HeLa cell extracts, gel filtration, recombinant protein reconstitution, permeabilized cell import assay |
The Journal of cell biology |
High |
8909533
|
| 1996 |
RanBP1 contains a leucine-rich nuclear export signal (NES) C-terminal to its Ran-binding domain that is necessary for its cytoplasmic localization; the isolated RBD lacking the NES accumulates in the nucleus. The cytoplasmic localization of RanBP1 is important for nuclear protein import. |
Subcellular fractionation, transfection of deletion/domain-swap constructs, permeabilized cell assay |
The Journal of cell biology |
High |
8794858
|
| 1997 |
RanBP1 forms a ternary complex with Ran-GTP and karyopherin beta (importin-β) and partially relieves the complete inhibition of RanGAP activity imposed by karyopherin beta, acting through competitive and non-competitive kinetic mechanisms at distinct sites on Ran. |
Solution binding assays, kinetic analysis of RanGAP activity in the presence of purified components |
The Journal of biological chemistry |
High |
8995296
|
| 1997 |
RanBP1 acts as a key disassembly intermediate for importin-β-related transport receptor–RanGTP complexes: RanBP1 stimulates the off-rate of RanGTP from the receptor by >100-fold, transiently releasing RanGTP·RanBP1 which is then driven by RanGAP to hydrolyze GTP. Release of importin-β additionally requires importin-α. |
In vitro binding and dissociation kinetics with purified transport receptors, RanGTP, and RanBP1; functional nuclear transport assays |
FEBS letters |
High |
9428644
|
| 1997 |
RanBP1 NES mutations that abolish cytoplasmic localization block Rev-mediated HIV-1 nuclear export, demonstrating that RanBP1 competes with or shares the CRM1-dependent nuclear export pathway used by Rev. This inhibitory effect is independent of RanBP1's ability to bind Ran. |
Mutational analysis of NES; reporter assays for Rev-mediated and CTE-mediated HIV-1 expression in transfected cells |
The Journal of biological chemistry |
Medium |
9111043
|
| 1997 |
RanBP1 binds Ran-GTP with nanomolar affinity and Ran-GDP with ~10 µM affinity; the difference is primarily due to a dramatically faster dissociation rate constant for the GDP-bound form. The C-terminal five residues of Ran are required for high-affinity RanBP1 binding to the GTP form. |
Fluorescence spectroscopy with nucleotide analogues, surface plasmon resonance (BIAcore), circular dichroism |
Biochemistry |
High |
9315840
|
| 1997 |
RanBP5, identified through a two-hybrid screen using RanBP1 as bait, binds RanBP1 as part of a trimeric RanBP1–Ran–RanBP5 complex; RanBP1 can relieve GAP-resistance of the RanBP5–RanGTP complex. |
Yeast two-hybrid, overlay assay, in vitro GAP assay with purified components |
Molecular and cellular biology |
Medium |
9271386
|
| 1997 |
Two distinct but overlapping binding domains for Ran-GTP and Ran-GDP/RanBP1 exist on p97 (importin-β); Cys-158 of p97 is required for Ran-GDP/RanBP1 binding but not Ran-GTP binding, and a Cys158Ala mutant p97 cannot support nuclear import. |
Site-directed mutagenesis and deletion analysis of p97; permeabilized cell import assay |
The Journal of biological chemistry |
High |
9045717
|
| 1997 |
The balance between RanBP1 and RCC1 is critical: restoring only one of these two proteins to co-depleted Xenopus egg extracts causes abnormal nuclear assembly and inhibits transport and DNA replication, rescued by addition of the other protein. The GTP/GDP-Ran balance is the essential functional parameter. |
Immunodepletion from Xenopus egg extracts, recombinant protein add-back, nuclear assembly and import assays |
Molecular biology of the cell |
High |
9348536
|
| 1997 |
Both mRNA species from the bidirectional Htf9-a/RanBP1 and Htf9-c promoter peak in S phase; cell cycle-dependent transcription is controlled at the transcriptional level by an S-phase-activated bidirectional promoter containing E2F and Sp1 recognition sites. |
Northern blotting of cell cycle fractions, transient reporter assays with promoter deletion constructs |
The Biochemical journal |
Medium |
9224656
|
| 1997 |
Deregulated (forced) expression of RanBP1 in murine fibroblasts disrupts cell cycle progression: it inhibits DNA replication, causes defective mitotic exit, and impairs chromatin decondensation at telophase-to-interphase transition. |
Stable transfection, BrdU incorporation, FACS analysis, microscopy |
Journal of cell science |
Medium |
9410874
|
| 1998 |
The RanBP1 Ran-binding domain (RBD) belongs structurally to the EVH1/WH1 domain superfamily shared by VASP, WASP, and Homer proteins. |
Computational sequence/structural analysis (domain recognition) |
FEBS letters |
Low |
9883880
|
| 1998 |
The distal E2F-b site plus a neighboring Sp1 element actively drive RanBP1 transcriptional upregulation in S phase, while the proximal E2F-c site mediates repression upon growth arrest; each site interacts with distinct E2F family members. |
Site-directed mutagenesis of promoter E2F sites, transient reporter assays, protein-binding assays |
The Journal of biological chemistry |
Medium |
10187822
|
| 1999 |
RanBP1 restores nuclear export of NFAT after RanQ69L-induced accumulation of CRM1 at the cytoplasmic face of the NPC, and both RanBP1 and the Ran-binding domains of RanBP2 promote release of CRM1 from the NPC. RanGTP is required for targeting export complexes to the cytoplasmic face of the NPC. |
Permeabilized cell export reconstitution assay, biochemical fractionation, in vitro reconstitution of CRM1-nucleoporin interactions |
The Journal of cell biology |
High |
10330396
|
| 1999 |
RanGTP bound to RanBP1 adopts a specific conformational state (state 2) distinct from free Ran-GTP; the RCC1–Ran–nucleotide ternary complex intermediate is detectable by 31P NMR, providing structural evidence for the exchange mechanism. |
31P NMR spectroscopy of purified Ran complexes; conformational analysis |
Biochemistry |
Medium |
10471274
|
| 1999 |
Isolated RBD from mammalian RanBP1 or S. pombe sbp1p is sufficient to rescue growth of sbp1-null fission yeast, and the RBD localizes to the nucleus rather than cytoplasm, indicating that cytoplasmic confinement is not required for essential RanBP1 function in yeast. |
Genetic complementation of sbp1 null yeast, subcellular localization of exogenous constructs |
Molecular biology of the cell |
Medium |
10397757
|
| 2000 |
RanBP1 shuttles actively through the nuclear pore: it accumulates in nuclei upon leptomycin B treatment (CRM1 inhibition), its import requires nuclear Ran-GTP (but not classical importin pathway), and an E37K mutation abolishes nuclear accumulation despite preserving ternary complex formation with Ran and importin-β. |
Leptomycin B treatment, cytoplasmic microinjection, permeabilized cell accumulation assay, nuclear import with exogenous karyopherins and RCC1 |
Molecular and cellular biology |
High |
10779340
|
| 2000 |
The essential biological activity of RanBP1 in yeast correlates specifically with its capacity to potentiate RanGAP activity toward Ran-GTP within karyopherin complexes, not with Ran-GTP binding per se or ternary complex formation. Mutants crippled for RanGAP co-activation cannot rescue growth even if they form ternary complexes. |
Random mutagenesis, in vitro biochemical assays (Ran binding, RanGAP stimulation, ternary complex formation), complementation of temperature-sensitive yrb1 yeast |
The Journal of biological chemistry |
High |
10660567
|
| 2001 |
Importin-β binding to Ran-GTP disrupts an intramolecular interaction between the basic patch (HRKK142) and the C-terminal DEDDDL motif of Ran, exposing the C-terminus and stimulating RanBP1 binding. Mutating the basic patch increases RanBP1 affinity and enables importin-β release without importin-α. CRM1 binding requires the basic patch but uses different Ran determinants than importin-β. |
Limited proteolysis protection assays, solution binding measurements with Ran mutants, in vitro dissociation assays |
Journal of molecular biology |
High |
11124902
|
| 2001 |
XMog1 (Xenopus Mog1) co-operates with RanBP1 to promote selective GTP loading onto Ran from GDP, and to facilitate RCC1-catalyzed generation of Ran-GTP in the nucleus; alone, neither protein is sufficient for this activity. |
Two-hybrid screening, in vitro nucleotide exchange and GTPase assays with purified components, yeast genetic rescue |
Journal of cell science |
Medium |
11686304
|
| 2002 |
FRET measurements show that binding of RanGTP to importin-β, RanBP1, or CRM1 all extend the C-terminal tail of Ran (reduced FRET between N-terminal GFP and C-terminal Alexa546). A Ran-GDP·RanBP1·importin-β ternary complex with extended tail is detected both in vitro and in intact cells via cytoplasmic FRET. |
FRET using Ran-GFP labeled with Alexa546; co-injection into living cells; in vitro reconstitution |
The Journal of biological chemistry |
High |
12034733
|
| 2003 |
RanBP1 overexpression specifically in mitosis induces splitting of mother and daughter centrioles at spindle poles, generating multipolar spindles; this requires microtubule integrity and Eg5 activity. A fraction of RanBP1 localizes at the centrosome during mitosis. |
Overexpression in mammalian cells, microscopy (centrosome and spindle staining), drug treatments (nocodazole, monastrol) |
Journal of cell science |
Medium |
12840069
|
| 2005 |
RanGAP1 is phosphorylated in vivo at Ser-358 by casein kinase II (CK2); this phosphorylation does not alter GAP catalytic activity but stabilizes formation of the ternary RanGAP1·Ran·RanBP1 complex in vivo. |
MALDI-TOF-MS phosphosite identification, site-directed mutagenesis at S358, in vitro kinase assay with CK2, co-immunoprecipitation of ternary complex |
Cell structure and function |
Medium |
16428860
|
| 2007 |
RANBP1 depletion in human cells causes prolonged prometaphase, hyperstable spindle microtubules, failure to recruit cyclin B1 to spindles, mislocalization of HURP (DLG7) away from plus-ends, and frequent lagging chromosomes in anaphase, indicating roles in microtubule dynamics regulation and prevention of merotelic attachments. |
siRNA knockdown in human cells, immunofluorescence microscopy, spindle stability assays |
Journal of cell science |
High |
17940066
|
| 2009 |
RanBP1 downregulation by RNAi activates caspase-3-dependent apoptosis in multiple transformed cell lines and increases their apoptotic response to taxol; this effect is absent in caspase-3-deficient MCF-7 cells, placing RanBP1 upstream of caspase-3 in the apoptotic pathway. |
siRNA knockdown, flow cytometry for apoptosis, taxol treatment, caspase-3 activity/deficiency comparison across cell lines |
Oncogene |
Medium |
19270727
|
| 2010 |
RanBP1 protein abundance peaks in mitosis and must decline in mid-to-late telophase for nuclear reformation. Mild RanBP1 overexpression persisting into late mitosis blocks chromatin decondensation, nuclear expansion, nuclear lamina reorganization, and NPC reassembly, with associated failure of importin-β-dependent NLS cargo reimport. Co-expression of importin-β mitigates these defects. |
Stable transfection with inducible overexpression, immunofluorescence, quantitative microscopy across cell cycle stages, importin-β co-expression rescue |
Chromosoma |
High |
20658144
|
| 2014 |
RanBP1 controls RCC1 enzymatic activity and partitioning between chromatin-bound and soluble pools in M-phase Xenopus egg extracts by forming a heterotrimeric RCC1/Ran/RanBP1 complex. This mechanism governs the spatial Ran-GTP gradient that guides spindle assembly. Additionally, phosphorylation of RanBP1 drives changes in chromatin-bound RCC1 dynamics at the metaphase-anaphase transition. |
Xenopus egg extract biochemistry, chromatin fractionation, in vitro exchange assays, immunodepletion/reconstitution, phosphorylation analysis |
Developmental cell |
High |
25458009
|
| 2014 |
Loss of Ranbp1 in mice selectively disrupts M phase of the cell cycle in cortical progenitors (both apical at E10.5 and basal at E14.5), resulting in microcephaly and specific reduction of layer 2/3 cortical projection neurons; Ranbp1-/- mice are not recovered live at birth and >60% are exencephalic. |
Targeted mouse knockout, BrdU/Ki67 proliferation assays, M-phase immunostaining (phospho-H3), cortical layer marker analysis |
Cerebral cortex |
High |
25452572
|
| 2018 |
RanBP1 regulates cortical neuron axon specification by controlling the cytoplasmic levels of the polarity kinase LKB1/Par4 through the nuclear export machinery; downstream of RanBP1, LKB1 acts via the STK25-GM130 pathway to regulate Golgi organization and promote axonogenesis. |
shRNA knockdown in cultured cortical neurons and in vivo, LKB1 localization assay, Golgi morphology analysis, epistasis with STK25 and GM130 |
Cell reports |
Medium |
30184488
|
| 2019 |
In animal cells (in contrast to fungi), RanBP1 dissociates nuclear export complexes by sequestering RanGTP away from the CRM1 export receptor, rather than via RanBP1-CRM1-RanGTP sequestration as in fungi. Animal RanBP1 forms a 1:1:2 (RanBP1:CRM1:RanGTP) nuclear export complex, whereas fungal RanBP1 forms a 1:1:1 complex; this mechanistic divergence is due to loss of affinity between animal RanBP1-RanGTP and CRM1, caused by non-conservation of key residues. |
In vitro reconstitution of export complexes, stoichiometry determination, mutational analysis of interface residues, biochemical binding assays |
eLife |
High |
31021318
|
| 2020 |
RanBP1 controls mitotic RCC1 dynamics in human somatic cells: RanBP1 degradation (auxin-inducible degron) alters metaphase chromatin-bound RCC1 exchange rates (FRAP/FLIP) and causes re-localization of the spindle assembly factor HURP, consistent with altered Ran-GTP gradients. |
Auxin-inducible degron (AID) depletion, FRAP and FLIP of RCC1-GFP, HURP immunolocalization in metaphase cells |
Cell cycle (Georgetown, Tex.) |
High |
32594833
|
| 2022 |
CD147 interacts with RanBP1 via its intracellular domain (CD147ICD) binding to the C-terminal tail of RanBP1; this interaction mediates CD147-regulated microtubule stability/dynamics and paclitaxel sensitivity in cancer cells. |
Co-immunoprecipitation, FRET, surface plasmon resonance (SPR), FRAP of microtubule dynamics, truncation analysis, xenograft models |
Oncogene |
High |
34974521
|
| 2022 |
RanBP1 is required for directional chemotaxis and front-to-rear polarity of migrating neural crest cells during development; this function involves LKB1/PAR4 regulated export downstream of Ran/RanBP1. |
Morpholino/RNAi knockdown in Xenopus neural crest cells, live cell chemotaxis assays, epistasis with LKB1 |
Developmental biology |
Medium |
36206829
|
| 2023 |
Oxidative stress concentrates RanBP1 in the nucleus through EGFR and PKA signaling pathways; pharmacological inhibition of EGFR or PKA reduces this relocalization, and mutational analysis identifies Ser-60 and Tyr-103 as critical residues for oxidant-induced nuclear accumulation. |
Subcellular fractionation, pharmacological inhibitors (EGFR/PKA), site-directed mutagenesis (S60A, Y103F), fluorescence microscopy |
European journal of cell biology |
Medium |
38011756
|